Comparison of the diagnostic value of fatty acid synthase (FASN) with alpha-methylacyl-CoA racemase (AMACR) as prostatic cancer tissue marker

Histopathology

Volumn 56, Issue 6, 2010, Pages 811-815

  Tischler, Verena ^a   Fritzsche, Florian R ^a   Gerhardt, Josefine ^a   Jäger, Christian ^a   Stephan, Carsten ^b   Jung, Klaus ^b,c   Dietel, Manfred ^b   Moch, Holger ^a   Kristiansen, Glen ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Berlin Institute for Urologic Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; FATTY ACID SYNTHASE; ALPHA-METHYLACYL-COA RACEMASE; FASN PROTEIN, HUMAN; ISOMERASE; TUMOR MARKER;

ADULT; CANCER INVASION; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; TISSUE MICROARRAY; UPREGULATION; AGED; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSTATIC NEOPLASMS;

AGED; FATTY ACID SYNTHASE, TYPE I; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES; TUMOR MARKERS, BIOLOGICAL;

EID: 77951740998     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03535.x     Document Type: Letter

References (8)

1. Epstein JI. Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy. Mod. Pathol. 2004 17 307 315.
2. Zhou M, Aydin H, Kanane H, Epstein JI. How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers? Am. J. Surg. Pathol. 2004 28 239 243.
3. Kristiansen G, Pilarsky C, Wissmann C et al. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. J. Pathol. 2005 205 359 376.
4. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 2007 7 763 777.
5. Shurbaji MS, Kalbfleisch JH, Thurmond TS. Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum. Pathol. 1996 27 917 921.
6. Baron A, Migita T, Tang D, Loda M. Fatty acid synthase: a metabolic oncogene in prostate cancer? J. Cell. Biochem. 2004 91 47 53.
7. Migita T, Ruiz S, Fornari A et al. Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J. Natl Cancer Inst. 2009 101 519 532.
8. Kristiansen G, Fritzsche FR, Wassermann K et al. GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Br. J. Cancer 2008 99 939 948.